SaskTel and Alcatel-Lucent launch LifeStat™ Remote Monitoring and Health Management enabling effective management of chronic illnesses
SaskTel and Alcatel-Lucent (Euronext Paris and NYSE: ALU)today announced the launch of external link LifeStat Remote Monitoring and Health Management, a service that records and transmits daily blood glucose and blood pressure readings, automatically creating confidential, easy-to-use reports that can be viewed online by the client, their caregivers, and the client’s healthcare professionals. The ongoing development and support of the LifeStat™ platform and applications will be managed by SaskTel and Alcatel-Lucent through their Salveo project, which is based in Saskatchewan.
The Salveo project is funded by SaskTel and Alcatel-Lucent with the primary objective of becoming a world leader in health and wellness telemonitoring software applications. A key focus of the Salveo project is the development of applications that will help keep people healthier and save costs in the healthcare system.
“LifeStat™ is a tremendous success story for SaskTel, Alcatel-Lucent and the Province of Saskatchewan,” said Ken Cheveldayoff, Minister of Crown Corporations for the Province of Saskatchewan. “Not only will LifeStat™ result in healthier people globally, it has created 20 new technical and professional positions in this province.”
“The LifeStat™ technology may hold the key to a new paradigm of diabetes and chronic illness management in primary care. We are looking forward to using this technology to introduce standard clinical diabetes management in the patient’s home with the help of the Home and Community Care team and the patient’s family physician,” said Dr. Sheldon Tobe, Sunnybrook Hospital Ontario.
SaskTel will market and sell the LifeStat™ service directly to consumers and healthcare providers in Canada, while Alcatel-Lucent will market and actively sell the Salveo platform to its global customers outside of Canada under the name Alcatel-Lucent Health and Wellness Application.
“We’re very excited to provide patients and caregivers with a powerful tool to aid in the effective management of chronic illnesses such as diabetes and hypertension,” said Robert Watson, SaskTel President and CEO.
Future LifeStat™ applications will include monitoring and reporting for chronic illnesses such as congestive heart failure, Chronic Obstructive Pulmonary Disease (COPD) and asthma.
“Alcatel-Lucent healthcare solutions help empower providers and improve patient care. With the launch of LifeStat™ and the grand opening of Salveo, SaskTel and Alcatel-Lucent are leveraging our combined expertise to deliver the next wave of innovative global telehealth solutions,” said Alex Giosa, President of Alcatel-Lucent Canada. “Interest has been strong, particularly due to the unlimited mobility and low cost per patient of the Salveo solution.”
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.